Assessment of the impact of a CD4+ T-cell testing laboratory improvement program
- PMID: 9625418
Assessment of the impact of a CD4+ T-cell testing laboratory improvement program
Abstract
Objective: To evaluate the effectiveness of the Centers for Disease Control and Prevention's CD4+ T-cell laboratory testing improvement program and the influence of other laboratory improvement programs on CD4+ T-cell testing practices.
Design: Surveys asking for practice changes and factors that influenced the changes, a survey of clinicians' perceptions of laboratory quality in CD4 testing, and analysis of data from the Model Performance Evaluation Program.
Interventions: Centers for Disease Control and Prevention interventions included a series of 3-day workshops on flow cytometry, CD4+ T-cell testing guidelines published in the Morbidity and Mortality Weekly Report, the Clinical Laboratory Improvement Amendments of 1988, and the Model Performance Evaluation Program.
Participants: All known laboratories in the United States that perform clinical CD4+ T-cell testing, workshop participants, and a sample of clinicians that treat patients infected with the human immunodeficiency virus.
Main outcome measures: Changes in practices, factors most influential in effecting change, and performance on samples mailed to laboratories by the Model Performance Evaluation Program; knowledge before and after presentation of material in workshops; and practicing clinicians' observations of any effects of changes in laboratory practices.
Results: Many existing laboratories changed practices as a result of both governmental and nongovernmental CD4+ T-cell testing improvement programs. Sources of influence varied with each testing practice. Perceptions that test results were more reproducible seemed to offset presumed increases in the time and cost of testing. Clinicians who had ordered CD4+ T-cell testing for more than 10 years noted some improvements in results reported.
Conclusions: As new complex testing methodologies are introduced into clinical and public health laboratories, the users seem to seek guidance in appropriate application of preanalytic, analytic, and postanalytic phases of the testing process. Testing improvement programs from a variety of sources were credited with changing practices and should continue to provide this guidance.
Similar articles
-
CD4+ T-cell testing practices as implications for training.Cytometry. 1997 Aug 15;30(4):181-5. Cytometry. 1997. PMID: 9298836
-
Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS.Cytometry B Clin Cytom. 2008;74 Suppl 1:S40-51. doi: 10.1002/cyto.b.20384. Cytometry B Clin Cytom. 2008. PMID: 18228554
-
CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing.Public Health Rep. 1990 Mar-Apr;105(2):167-71. Public Health Rep. 1990. PMID: 2157234 Free PMC article.
-
CD4 cell monitoring for HIV/AIDS: old options; new insights.SADJ. 2001 Dec;56(12):602-5. SADJ. 2001. PMID: 11887447 Review.
-
Proficiency testing in laboratory medicine: uses and limitations.Arch Pathol Lab Med. 1998 Jan;122(1):15-30. Arch Pathol Lab Med. 1998. PMID: 9448012 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials